Hints and tips:
Related Special Reports
...Pharma groups and biotechs can be locked into contracts with WuXi for up to five years into the future, said Crowley....
...Mentioned in this podcast: US biotech fundraising boom ends 2-year deal drought Is the EU’s Covid recovery fund failing?...
...German pharma group Boehringer Ingelheim has struck an up to $1bn partnership with a UK biotech to develop treatments for chronic liver disease that aim to harness the organ’s capacity to regenerate....
...In other words, these products should probably be seen as a manifestation of risk-on in the new bull market, rather than a defensive play on yield....
...Specification: Biopsychology Click the link below to read the and then answer the questions: UK biotech group raises £48mn for Alzheimer’s research The article notes that “neurons are the fundamental...
...[MUSIC PLAYING] American biotech companies are rushing to raise funds on US stock markets at the fastest rate since the biotech boom of the pandemic....
...AstraZeneca is a specialist in cancer treatments, making $17bn and 37 per cent of sales from oncology products in 2023....
...Many European biotechs are bought by large drugmakers long before they have an approved product....
...A total of nine biotechs have gone public on US markets this quarter, raising $1.4bn between them....
...Increases in the volume of products consumers bought contributed 4 per cent to L’Oréal’s 2023 revenue growth, while the rest came from pricing, not vice versa as wrongly stated in an article on February...
Higher prices for smaller products are hitting economies and consumers across the world
...The closely followed SPDR S&P Biotech ETF tumbled almost two-thirds from its 2021 high, weighed down by rising interest rates and a backlash to pandemic-era over-optimism about new drugs....
...Chinese biotech companies fell, with WuXi Biologics retreating 21 per cent, WuXi AppTec dropping 18 per cent and Pharmaron down 15 per cent....
...“New dermatology products will grow the market....
...US lawmakers have put the sector under scrutiny in relations with China and are seeking to restrict companies with federal funding from contracting with “foreign adversary” biotech groups of “concern” deemed...
...A classic example of a yield-enhancing structured product is a so-called “covered call”: a purchase of the S&P 500 index and a simultaneous sale of a one-month call option on the index....
...Put simply, biotech uses living organisms to create new products, technologies and solutions....
...P&G’s earnings reflected a “barbell” trend that has seen some consumers pay up for high-performing products while others trade down to cheaper private label goods, said English....
...The EU has agreed to ban products made with forced labour in a move that could raise trade tensions with China....
...Spravato, a nasal spray based on a molecule from the psychedelic drug ketamine used to treat depression, already ranks as Johnson & Johnson’s fastest-growing product....
...It says it needs improved access to capital, but it claims to be one of the largest biotech fundraisers in recent years....
...HOLD: Ultimate Products (ULTP) Ultimate Products recorded a drop in revenue in its interim results as the homeware business was hit by supermarket overstocking, revenue deferrals because of supply chain...
...These techniques — the “holy grail of biotech” — allow genetic improvements to be made remotely with “the ease of a software update”....
...Large drugmakers have also underperformed, with the S&P 500 pharmaceutical sub-index heading for its worst performance relative to the broader S&P 500 in at least 20 years....
...Investors will watch next week for first-quarter gross domestic product data to gauge the strength of the US economy....
International Edition